➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Harvard Business School
Medtronic
Baxter
AstraZeneca
McKinsey
Mallinckrodt

Last Updated: June 5, 2020

DrugPatentWatch Database Preview

Interpharm Company Profile


Email this page to a colleague

» See Plans and Pricing

« Back to Dashboard

What is the competitive landscape for INTERPHARM, and what generic and branded alternatives to INTERPHARM drugs are available?

INTERPHARM has seventeen approved drugs.



Summary for Interpharm
US Patents:0
Tradenames:8
Ingredients:8
NDAs:17
Patent Litigation for Interpharm: See patent lawsuits for Interpharm

Drugs and US Patents for Interpharm

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Interpharm TOLAZAMIDE tolazamide TABLET;ORAL 071271-001 Sep 23, 1986 DISCN No No   Start Trial   Start Trial
Interpharm SULFAMETHOXAZOLE AND TRIMETHOPRIM sulfamethoxazole; trimethoprim TABLET;ORAL 071300-001 Oct 27, 1987 DISCN No No   Start Trial   Start Trial
Interpharm DOXYCYCLINE HYCLATE doxycycline hyclate CAPSULE;ORAL 062763-001 Sep 2, 1988 DISCN No No   Start Trial   Start Trial
Interpharm METOCLOPRAMIDE HYDROCHLORIDE metoclopramide hydrochloride TABLET;ORAL 071213-001 Sep 24, 1986 DISCN No No   Start Trial   Start Trial
Interpharm DISOPYRAMIDE PHOSPHATE disopyramide phosphate CAPSULE;ORAL 071190-001 Jan 15, 1987 DISCN No No   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
AstraZeneca
Colorcon
Baxter
Medtronic
Harvard Business School

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.